Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Basidiomycota, a diverse phylum of fungi that includes mushrooms like Ganoderma lucidum (Reishi), Lentinula edodes (Shiitake), and Trametes versicolor (Turkey Tail), has been investigated for its antimicrobial properties as potential alternatives or adjuncts to traditional antibiotics. Scientific studies have shown that extracts from some Basidiomycota species possess in vitro antibacterial activity against a range of pathogenic bacteria, including Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. The mechanisms of action are attributed to bioactive compounds such as polysaccharides, terpenoids, and phenolic compounds found within these mushrooms.

However, while laboratory results are promising, clinical evidence supporting the use of Basidiomycota extracts as effective antibiotic alternatives in humans is limited. Most studies have been conducted in vitro or in animal models, and there is a lack of large-scale, high-quality human trials demonstrating clear efficacy and safety. Some Basidiomycota species have a long history of use in traditional medicine for supporting immune health, which may contribute indirectly to infection resistance, but this is distinct from direct antibiotic action.

In summary, there is scientific evidence at the preclinical level supporting antimicrobial properties of Basidiomycota extracts, but clinical validation is lacking. Therefore, their use as antibiotic alternatives is supported by some scientific data, but the evidence is preliminary (rated 2/5).

More about Basidiomycota
More about Antibiotics (alternatives to)

Other ingredients used for Antibiotics (alternatives to)

Other health conditions supported by Basidiomycota

Products containing Basidiomycota